George A. Doss

3.5k total citations
95 papers, 2.6k citations indexed

About

George A. Doss is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, George A. Doss has authored 95 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 32 papers in Organic Chemistry and 24 papers in Pharmacology. Recurrent topics in George A. Doss's work include Pharmacogenetics and Drug Metabolism (23 papers), Inflammatory mediators and NSAID effects (14 papers) and Carbohydrate Chemistry and Synthesis (12 papers). George A. Doss is often cited by papers focused on Pharmacogenetics and Drug Metabolism (23 papers), Inflammatory mediators and NSAID effects (14 papers) and Carbohydrate Chemistry and Synthesis (12 papers). George A. Doss collaborates with scholars based in United States, Japan and Canada. George A. Doss's co-authors include Thomas A. Baillie, Ralph A. Stearns, Wei Tang, Margaret R. Davis, Dennis Dean, Kwan Leung, Sijiu Shen, Michael R. Marchick, Lance R. Pohl and Kelem Kassahun and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Agricultural and Food Chemistry and Journal of Medicinal Chemistry.

In The Last Decade

George A. Doss

94 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
George A. Doss United States	29	944	876	681	519	497	95	2.6k
Ralph A. Stearns United States	27	1.3k 1.3×	715 0.8×	303 0.4×	590 1.1×	370 0.7×	68	2.5k
Deborah A. Nicoll‐Griffith Canada	26	1.2k 1.3×	1.1k 1.3×	495 0.7×	519 1.0×	481 1.0×	60	3.1k
Abdul Mutlib United States	24	825 0.9×	902 1.0×	405 0.6×	339 0.7×	388 0.8×	61	2.5k
Wendel L. Nelson United States	28	783 0.8×	1.0k 1.2×	547 0.8×	386 0.7×	349 0.7×	134	2.7k
Nathalie Chauret Canada	25	616 0.7×	607 0.7×	437 0.6×	315 0.6×	410 0.8×	64	1.9k
Deepak Dalvie United States	33	1.5k 1.6×	1.7k 2.0×	831 1.2×	609 1.2×	389 0.8×	76	4.0k
Kamlesh P. Vyas United States	26	854 0.9×	606 0.7×	248 0.4×	494 1.0×	421 0.8×	58	2.3k
Cuyue Tang United States	25	839 0.9×	631 0.7×	214 0.3×	627 1.2×	278 0.6×	66	2.2k
Wei Tang United States	27	1.3k 1.4×	778 0.9×	292 0.4×	630 1.2×	385 0.8×	75	2.6k
Li‐Wei Zou China	30	459 0.5×	950 1.1×	871 1.3×	273 0.5×	666 1.3×	106	2.8k

Countries citing papers authored by George A. Doss

Since Specialization

Citations

This map shows the geographic impact of George A. Doss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George A. Doss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George A. Doss more than expected).

Fields of papers citing papers by George A. Doss

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George A. Doss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George A. Doss. The network helps show where George A. Doss may publish in the future.

Co-authorship network of co-authors of George A. Doss

This figure shows the co-authorship network connecting the top 25 collaborators of George A. Doss. A scholar is included among the top collaborators of George A. Doss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George A. Doss. George A. Doss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bateman, Thomas J., John S. Debenham, Thomas F. Walsh, et al.. (2009). Glutathione S-Transferase Catalyzed Desulfonylation of a Sulfonylfuropyridine. Drug Metabolism and Disposition. 38(1). 108–114. 9 indexed citations

Chu, Xiaoyan, Yuexia Liang, Xiaoxin Cai, et al.. (2008). Metabolism and Renal Elimination of Gaboxadol in Humans: Role of UDP-Glucuronosyltransferases and Transporters. Pharmaceutical Research. 26(2). 459–468. 16 indexed citations

Pasternak, Alexander, George A. Doss, Nancy N. Tsou, et al.. (2008). Conformational studies of 3-amino-1-alkyl-cyclopentane carboxamide CCR2 antagonists leading to new spirocyclic antagonists. Bioorganic & Medicinal Chemistry Letters. 18(4). 1374–1377. 10 indexed citations

Morriello, Gregori J., Robert J. DeVita, Sander G. Mills, et al.. (2007). Fused bicyclic pyrrolizinones as new scaffolds for human NK1 antagonists. Bioorganic & Medicinal Chemistry. 16(5). 2156–2170. 24 indexed citations

Karanam, Bindhu V., Maria Madeira, Scott A. Bradley, et al.. (2007). Absorption, Metabolism, and Excretion of [14C]MK-0524, a Prostaglandin D2 Receptor Antagonist, in Humans. Drug Metabolism and Disposition. 35(7). 1196–1202. 24 indexed citations

Li, Ying, J. Greg Slatter, Zhoupeng Zhang, et al.. (2007). In Vitro Metabolic Activation of Lumiracoxib in Rat and Human Liver Preparations. Drug Metabolism and Disposition. 36(2). 469–473. 34 indexed citations

Plummer, Christopher W., Paul E. Finke, Sander G. Mills, et al.. (2005). Synthesis and activity of 4,5-diarylimidazoles as human CB1 receptor inverse agonists. Bioorganic & Medicinal Chemistry Letters. 15(5). 1441–1446. 46 indexed citations

Ashton, Wallace T., Hong Dong, Kathryn A. Lyons, et al.. (2005). Dipeptidyl peptidase IV inhibitors derived from β-aminoacylpiperidines bearing a fused thiazole, oxazole, isoxazole, or pyrazole. Bioorganic & Medicinal Chemistry Letters. 15(9). 2253–2258. 51 indexed citations

Debenham, John S., Thomas F. Walsh, Junying Wang, et al.. (2005). Synthesis of functionalized 1,8-naphthyridinones and their evaluation as novel, orally active CB1 receptor inverse agonists. Bioorganic & Medicinal Chemistry Letters. 16(3). 681–685. 21 indexed citations

10.

Doss, George A., et al.. (2004). IDENTIFICATION AND METABOLISM OF A NOVEL DIHYDROHYDROXY-S-GLUTATHIONYL CONJUGATE OF A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR AGONIST, MK-0767 [(±)-5-[(2,4-DIOXOTHIAZOLIDIN-5-YL)METHYL]-2-METHOXY-N-[[(4-TRIFLUOROMETHYL) PHENYL]METHYL]BENZAMIDE], IN RATS. Drug Metabolism and Disposition. 32(10). 1154–1161. 7 indexed citations

11.

Miller, Randall R., George A. Doss, & Ralph A. Stearns. (2004). IDENTIFICATION OF A HYDROXYLAMINE GLUCURONIDE METABOLITE OF AN ORAL HYPOGLYCEMIC AGENT. Drug Metabolism and Disposition. 32(2). 178–185. 14 indexed citations

12.

Dean, Brian, Steve W. Chang, George A. Doss, Christopher D. King, & Paul E. Thomas. (2004). Glucuronidation, oxidative metabolism, and bioactivation of enterolactone in rhesus monkeys. Archives of Biochemistry and Biophysics. 429(2). 244–251. 27 indexed citations

13.

Ashton, Wallace T., Hong Dong, George A. Doss, et al.. (2004). Diastereoselective synthesis and configuration-dependent activity of (3-substituted-cycloalkyl)glycine pyrrolidides and thiazolidides as dipeptidyl peptidase IV inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(4). 859–863. 19 indexed citations

14.

Bao, Jianming, Frank Kayser, Robert K. Baker, et al.. (2004). Potent Kv1.3 inhibitors from correolide—modification of the C18 position. Bioorganic & Medicinal Chemistry Letters. 15(2). 447–451. 18 indexed citations

15.

Tang, Wei, Ralph A. Stearns, Randall R. Miller, et al.. (2002). Metabolism of a Thiazole Benzenesulfonamide Derivative, a Potent and Selective Agonist of the Human β3-Adrenergic Receptor, in Rats: Identification of a Novel Isethionic Acid Conjugate. Drug Metabolism and Disposition. 30(7). 778–787. 8 indexed citations

16.

Matthews, Catherine Z., Eric Woolf, Ralph S. Mazenko, et al.. (2002). Determination of efavirenz, a selective non-nucleoside reverse transcriptase inhibitor, in human plasma using HPLC with post-column photochemical derivatization and fluorescence detection. Journal of Pharmaceutical and Biomedical Analysis. 28(5). 925–934. 38 indexed citations

17.

Kari, Prasad H., et al.. (2000). Metabolism of A Dopamine D4-Selective Antagonist in Rat, Monkey, and Humans: Formation of A Novel Mercapturic Acid Adduct. Drug Metabolism and Disposition. 28(6). 633–642. 9 indexed citations

18.

Leung, Kwan, Dosinda Cohn, Randall R. Miller, et al.. (1996). Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species.. Drug Metabolism and Disposition. 24(7). 753–760. 8 indexed citations

19.

Huskey, Su-Er W., George A. Doss, R R Miller, William R. Schoen, & S H Chiu. (1994). N-glucuronidation reactions. II. Relative N-glucuronidation reactivity of methylbiphenyl tetrazole, methylbiphenyl triazole, and methylbiphenyl imidazole in rat, monkey, and human hepatic microsomes.. Drug Metabolism and Disposition. 22(4). 651–658. 25 indexed citations

20.

Doss, George A., et al.. (1993). Microbial Transformation of L-696, 474, a Novel Cytochalasin as an Inhibitor of HIV-1 Protease. Journal of Natural Products. 56(5). 755–761. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact